Colitis patients who don't respond well to conventional// therapy may soon get help from a bacteria mixture, reports science portal www.eurekalert.org.
Richard Fedorak, a professor of gastroenterology at the University of Alberta, and researchers from the University of Bologna in Italy and the University of North Carolina administered probiotic bacteria mixture VSL#3 over a six-week period to 30 patients aged 18-65.
Probiotics are preparations of living microbial cells that, when ingested, are thought to positively influence the composition of microbes in the gut and improve the health of the intestine.
Remission of colitis was achieved in 63 percent of patients, while another 23 percent responded with improvement in their symptoms and with healing of the colon's lining. There were no adverse effects to the medication, the study said.
In this open label clinical trial, 86 percent of those treated with probiotic bacteria mixture VSL#3 experienced relief of their mild to moderate ulcerative colitis.
The researchers found that the majority of patients taking VSL#3 for six weeks improved their ulcerative colitis. While "bad" bacteria have been flagged as potential culprits in the cause of inflammatory diseases of the bowel, in this case, the ingestion of supplemental "good" bacteria (probiotics) to the intestine proved beneficial in treating ulcerative colitis, Fedorak said.
The VSL#3 can be considered an important potential treatment for those patients who don't respond to conventional therapy such as mesalamine or 5ASA, he said.
Page: 1 Related medicine news :1
. Kidney Stones - Interesting New Research implicates bacteria as its cause2
. Just spice it up!!!!! Anti bacterial effects of spices unraveled in the West3
. Dangerous food bacteria4
. Tongue piercing leads to bacterial infection5
. Honey curbs bacteria in the oral cavity6
. Identifying bacteria made amiable7
. The Effectiveness Of Antibacterial Products In Reducing Infection 8
. Light can help fight gum bacteria
. Asthma may increase the risk for bacterial infection of the lungs10
. Cystic fibrosis patients may require a new treatment for bacterial infection11
. Risks of heart attack related to bacteria in gum plaque